Yougen Wu

703 total citations
24 papers, 573 citations indexed

About

Yougen Wu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yougen Wu has authored 24 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Yougen Wu's work include Vitamin D Research Studies (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Cell death mechanisms and regulation (2 papers). Yougen Wu is often cited by papers focused on Vitamin D Research Studies (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Cell death mechanisms and regulation (2 papers). Yougen Wu collaborates with scholars based in China and United States. Yougen Wu's co-authors include Gong Yang, Yang Hong, Yunjiao Zhou, Xiufeng Pang, Mingyao Liu, Jieqiong Wang, Zhengfang Yi, Lina Yang, Yinghua Li and Juan Zhou and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Yougen Wu

23 papers receiving 565 citations

Peers

Yougen Wu
Mu-Xin Wei China
Jiao Li China
Lei Gong China
Jianlin Ren China
Xiaoyu Cao China
Ravichandran Senthilkumar India
Arisa Imsumran Thailand
Abdul Basit Baba India
Ningning Liu China
Chandan Kanta Das India
Mu-Xin Wei China
Yougen Wu
Citations per year, relative to Yougen Wu Yougen Wu (= 1×) peers Mu-Xin Wei

Countries citing papers authored by Yougen Wu

Since Specialization
Citations

This map shows the geographic impact of Yougen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yougen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yougen Wu more than expected).

Fields of papers citing papers by Yougen Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yougen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yougen Wu. The network helps show where Yougen Wu may publish in the future.

Co-authorship network of co-authors of Yougen Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yougen Wu. A scholar is included among the top collaborators of Yougen Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yougen Wu. Yougen Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yougen, et al.. (2024). Height and cancer risk in East Asians: Evidence from a prospective cohort study and Mendelian randomization analyses. Cancer Epidemiology. 92. 102647–102647. 1 indexed citations
2.
Zhang, Lin, Zhaohui Tong, Zhiping Wu, et al.. (2024). Encapsulated lignin-based slow-release manganese fertilizer with reduced cadmium accumulation in rice (Oryza sativa L.). International Journal of Biological Macromolecules. 262(Pt 1). 130019–130019. 6 indexed citations
3.
Wu, Yougen, Wei Wang, Yang Wang, et al.. (2024). Association of sleep traits with benign prostatic hyperplasia in middle‐aged and elderly men: A prospective analysis in UK Biobank. Geriatrics and gerontology international. 24(7). 675–682. 1 indexed citations
4.
Wu, Yougen, Wenyu Zhu, Jing Wang, et al.. (2022). Using machine learning for mortality prediction and risk stratification in atezolizumab‐treated cancer patients: Integrative analysis of eight clinical trials. Cancer Medicine. 12(3). 3744–3757. 12 indexed citations
5.
6.
Liu, Yan, Jing Mao, Yougen Wu, et al.. (2020). The antibiofilm and collagen‐stabilizing effects of proanthocyanidin as an auxiliary endodontic irrigant. International Endodontic Journal. 53(6). 824–833. 31 indexed citations
7.
Wu, Yougen, et al.. (2019). Hematopoietic and lymphatic cancers in patients with periodontitis: a systematic review and meta-analysis. Medicina oral, patología oral y cirugía bucal. 25(1). e21–e28. 12 indexed citations
8.
9.
10.
Wu, Yougen, et al.. (2017). Association of lactase 13910 C/T polymorphism with bone mineral density and fracture risk: a meta-analysis. Journal of Genetics. 96(6). 993–1003. 2 indexed citations
11.
Wu, Yougen, et al.. (2017). Safety and efficacy of Ofatumumab in chronic lymphocytic leukemia: a systematic review and meta-analysis. Hematology. 22(10). 578–584. 8 indexed citations
12.
Shi, Jindong, Jingjing Feng, Juan Xie, et al.. (2017). Targeted blockade of TGF-β and IL-6/JAK2/STAT3 pathways inhibits lung cancer growth promoted by bone marrow-derived myofibroblasts. Scientific Reports. 7(1). 8660–8660. 36 indexed citations
13.
Zhou, Juan, Yinghua Li, Lina Yang, et al.. (2016). Stanniocalcin 2 improved osteoblast differentiation via phosphorylation of ERK. Molecular Medicine Reports. 14(6). 5653–5659. 25 indexed citations
14.
Lu, Lili, Jingshu Wang, Yougen Wu, Ping Wan, & Gong Yang. (2016). Rap1A promotes ovarian cancer metastasis via activation of ERK/p38 and notch signaling. Cancer Medicine. 5(12). 3544–3554. 62 indexed citations
15.
Wu, Yougen, Juan Zhou, Yinghua Li, et al.. (2015). Rap1A Regulates Osteoblastic Differentiation via the ERK and p38 Mediated Signaling. PLoS ONE. 10(11). e0143777–e0143777. 47 indexed citations
16.
Yang, Lina, Yunjiao Zhou, Yinghua Li, et al.. (2014). Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells. Cancer Letters. 357(2). 520–526. 112 indexed citations
17.
Pang, Xiufeng, Yuanyuan Wu, Yougen Wu, et al.. (2011). (−)-Gossypol Suppresses the Growth of Human Prostate Cancer Xenografts via Modulating VEGF Signaling–Mediated Angiogenesis. Molecular Cancer Therapeutics. 10(5). 795–805. 60 indexed citations
18.
19.
Pang, Xiufeng, Li Zhang, Yougen Wu, et al.. (2010). Methyl 2-Cyano-3,11-dioxo-18-olean-1,12-dien-30-oate (CDODA-Me), a Derivative of Glycyrrhetinic Acid, Functions as a Potent Angiogenesis Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 335(1). 172–179. 16 indexed citations
20.
Rao, Yi, et al.. (2008). [Advances in studies compatibility applied toattenuation and synergy of Tripterygium wilfordii].. PubMed. 33(14). 1658–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mu-Xin Wei Breakdown of academic impact, for papers by Jiao Li Breakdown of academic impact, for papers by Lei Gong Breakdown of academic impact, for papers by Jianlin Ren Breakdown of academic impact, for papers by Xiaoyu Cao Breakdown of academic impact, for papers by Ravichandran Senthilkumar Breakdown of academic impact, for papers by Arisa Imsumran Breakdown of academic impact, for papers by Abdul Basit Baba Breakdown of academic impact, for papers by Ningning Liu Breakdown of academic impact, for papers by Chandan Kanta Das
Rankless by CCL
2026